Principal Financial Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AVM
Principal Financial Group's BEAM Position: Q2 2026 in Review
Principal Financial Group opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 7,009 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2069 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in BEAM as recently as Q2 2024.
Principal Financial Group first reported a position in BEAM in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.69M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Principal Financial Group held 7,009 shares of Beam Therapeutics worth $241K as of Q2 2026.
- Beam Therapeutics was a new Principal Financial Group position in Q2 2026.
- Beam Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2069 holding.
- Principal Financial Group first reported a position in Beam Therapeutics in Q4 2020 and has held it in 16 quarters since.
- Principal Financial Group's Beam Therapeutics position peaked at $2.69M in Q2 2021.
- 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.